Tender Details
Ref No 29833301
Document

Tender Notice

Bidding

Not specified

Short Description

Contracting Of A Production Service For A Purified Lentiviral Vector Solution Within The Framework Of The Ici24/00101 Project And Title “Phase I Clinical Trial, First In Humans, To Evaluate The Safety Of Genetically Modified Autologous T Lymphocytes That Secrete Bcmaxcd3 Bispecific Antibodies For Refractory Or Relapsed Multiple Myeloma”, Financed By The Carlos Iii Health Institute (Isciii) And Co-Financed By The European Union.

Deadline *
Date 18 Aug 2026
* The estimated cost, values & dates are indicative only. Please read tender document for accurate information.
Client Address
Location Spain
More Information
Know More

FREE Trial Plan For All New Users!

Start your Business.

Similar Tenders

Qualification Scheme Technical Advice

Sdp Supply Of Medicinal Products

Voluntary Intermodal Sealift Agreement Visa 2024 Renewal

Delivery Of Medicinal Products For The Needs Of Mbal Haskovo Ad

Open Ended Justice Involved Supportive Housing Jish

Qualifizierungssystem Kompaktstationen

Delivery Of Medicinal Products For The Needs Of Mbal Haskovo Ad

WhatsApp Chat